| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |